Noemi Reguart News Today

Jemperli plus chemotherapy demonstrated improvement in overall survival compared with Keytruda and chemotherapy in patients with treatment-naïve, nonsquamous non–small cell lung cancer.

Dostarlimab plus chemotherapy elicited a higher objective response rate and showcased a numerical improvement in overall survival compared with pembrolizumab and chemotherapy in patients with treatment-naïve, nonsquamous non–small cell lung cancer.

Artidis AG: ARTIDIS enters clinical collaboration to investigate nanomechanical profiling as a novel diagnostic and treatment optimization approach in patients with lung cancer the ation in the ARTIDISNet platform . In this research collaboration, ARTIDIS and teams from the University of Barcelona and Hospital Clínic de Barcelona will perform comparative analyses of nanomechanical profiles of cancer tissue and sub-cellular components, i.e. tumor microenvironments (TME), in human lung biopsie...